It appears that your browser has cookies disabled.
The website requires your browser to enable cookies in order to login.
Please enable cookies and reload this page.
Advancing Cancer Diagnostics, Improving Lives
Seleziona il tuo paese / regione
La tua posizione non corrisponde all'indirizzo (URL), vuoi cambiarla?
Ogni paese/regione può avere una propria serie di requisiti normativi e pratiche mediche. Le informazioni che si trovano su ogni versione del nostro sito Web per paese sono specifiche e applicabili solo a quel paese/regione. Ciò include (ma non è limitato a) tutti i dettagli/disponibilità del prodotto, la documentazione, i prezzi e le promozioni.
FGFR3 / IGH t(4;14) Fusion probe hybridized to MM patient material showing t(4;14) translocation (2RG1R1G). Image kindly provided by Prof. Jauch, Heidelberg.
FGFR3 / IGH t(4;14) Fusion probe hybridized to MM patient material showing t(4;14) translocation (2RG1R1G). Image kindly provided by Prof. Jauch, Heidelberg.
IVD FGFR3/IGH
The t(4;14) translocation is undetectable by conventional cytogenetics. The breakpoints on chromosome 4 occur within an approximately 113-kb region located in small part of a conserved gene cluster including the transforming acidic coiled-coil protein 3 (TACC3), fibroblast growth factor receptor 3 (FGFR3), and multiple myeloma SET domain-containing protein (MMSET). The translocation is indicative for poor survival and poor response to chemotherapy. The FGFR3/IGH t(4;14)(p16;q32) Fusion specific FISH probe is optimized to detect the reciprocal translocation t(4;14) in a dual-color, dual-fusion assay.
References: Chesi et al, 1997, Nat Genet, 16; 260-264. Finelli et al, 1999, Blood, 94; 724-732.
